[Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001539:Bendroflumethiazide / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009248:Nadolol; D010919:Placebos; D011412:Propanolamines / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D010919:Placebos; D011412:Propanolamines; D009248:Nadolol; D001539:Bendroflumethiazide
Studio controllato dell'efficacia antiipertensiva dell'associazione di nadololo e bendroflumetiazide rispetto al nadololo da solo ed al placebo.